Stability of pharmaceutical salts in solid oral dosage forms

Drug Development and Industrial Pharmacy
Haichen NieQi Tony Zhou

Abstract

Using pharmaceutical salts in solid dosage forms can raise stability concerns, especially salt dissociation which can adversely affect the product performance. Therefore, a thorough understanding of the salt instability encountered in solid-state formulations is imperative to ensure the product quality. The present article uses the fundamental theory of acid base, ionic equilibrium, relationship of pH and solubility as a starting point to illustrate and interpret the salt formation and salt disproportionation in pharmaceutical systems. The criteria of selecting the optimal salt form and the underlying theory of salt formation and disproportionation are reviewed in detail. Factors influencing salt stability in solid dosage forms are scrutinized and discussed with the case studies. In addition, both commonly used and innovative strategies for preventing salt dissociations in formulation, on storage and during manufacturing will be suggested herein. This article will provide formulation scientists and manufacturing engineers an insight into the mechanisms of salt disproportionation and salt formation, which can help them to avoid and solve the instability issues of pharmaceutical salts in the product design.

References

Sep 1, 1978·Journal of Pharmaceutical Sciences·Z T Chowhan
Feb 1, 1979·Journal of Pharmaceutical Sciences·J B Bogardus, R K Blackwood
Jan 1, 1977·Journal of Pharmaceutical Sciences·S M BergeD C Monkhouse
Sep 1, 1989·Pharmaceutical Research·T T KararliP M Finnegan
Aug 1, 1985·Journal of Pharmaceutical Sciences·B D Anderson, R A Conradi
Dec 1, 1972·Journal of Pharmaceutical Sciences·S F Kramer, G L Flynn
Jun 1, 1967·Journal of Pharmaceutical Sciences·L Z Benet, J E Goyan
Dec 1, 1983·Journal of Pharmaceutical Sciences·L Van CampenG Zografi
Feb 1, 1993·Pharmaceutical Research·M B MaurinR Hogan
Apr 1, 1997·The Journal of Pharmacy and Pharmacology·J KelderV Nickolson
Jul 8, 1998·Pharmaceutical Development and Technology·W Q Tong, G Whitesell
Oct 31, 1998·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·C A ScheefP C Schmidt
Jul 7, 1999·Journal of Pharmaceutical Sciences·A T SerajuddinS A Varia
Aug 16, 2000·Journal of Pharmaceutical Sciences·V GallardoJ D Durán
Sep 12, 2000·Journal of Pharmaceutical Sciences·L S Taylor, F W Langkilde
Mar 29, 2001·Journal of Pharmacological and Toxicological Methods·C A Lipinski
May 30, 2001·Journal of Pharmaceutical and Biomedical Analysis·M M Al-OmariA M Jaber
Dec 12, 2002·Journal of the American Chemical Society·Xiaoming ChenJoseph G Stowell
Oct 1, 1957·Journal of the American Pharmaceutical Association·E NELSON
Oct 1, 1963·Journal of Pharmaceutical Sciences·M I BLAKE, D A NONA
Nov 1, 1964·Journal of Pharmaceutical Sciences·L W DITTERTD R REESE
Feb 14, 2004·Advanced Drug Delivery Reviews·Geoff G Z ZhangYihong Qiu
Apr 15, 2004·International Journal of Pharmaceutics·Adrian C WilliamsSteven W Booth
May 17, 2005·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Ilse WeutsGuy Van den Mooter
Jun 7, 2005·International Journal of Pharmaceutics·Debra S HausmanAdel Sakr
Jul 20, 2005·Pharmaceutical Research·Stuart WardStephen J Ebbens
Sep 2, 2005·Journal of Pharmaceutical Sciences·Shoufeng LiAbu T M Serajuddin
Aug 26, 2006·Pharmaceutical Research·Ramprakash GovindarajanRaj Suryanarayanan
Nov 15, 2006·Pharmaceutical Research·Peter GuerrieriLynne S Taylor
Nov 30, 2006·Applied Spectroscopy·Mark J Henson, Lin Zhang
Feb 14, 2007·International Journal of Pharmaceutics·Erika A ZannouAbu T M Serajuddin
Apr 25, 2007·Journal of Pharmaceutical Sciences·Simon N BlackRon J Roberts
Apr 28, 2007·Molecular Pharmaceutics·Scott L ChildsAeri Park
Jul 10, 2007·Advanced Drug Delivery Reviews·Abu T M Serajuddin
Oct 7, 2008·Journal of Pharmaceutical Sciences·Chitra TelangMichael Mathew

❮ Previous
Next ❯

Citations

Nov 27, 2018·Magnetic Resonance in Chemistry : MRC·Inês C B MartinsLuís Mafra
Jan 18, 2021·Toxicological Sciences : an Official Journal of the Society of Toxicology·Barbara LenzHolger Fischer
Feb 14, 2021·International Journal of Pharmaceutics·Anthony LaiChristopher J H Porter
Dec 7, 2018·Crystal Growth & Design·Yitian M Chen, Naír Rodríguez-Hornedo
Jul 18, 2018·Molecular Pharmaceutics·David A HirshRobert W Schurko

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.